5-HT1B receptor explained

5-hydroxytryptamine receptor 1B also known as the 5-HT1B receptor is a protein that in humans is encoded by the HTR1B gene.[1] [2] The 5-HT1B receptor is a 5-HT receptor subtype.[3]

Tissue distribution and function

5-HT1B receptors are widely distributed throughout the central nervous system with the highest concentrations found in the frontal cortex, basal ganglia, striatum, and the hippocampus.[4] The function of the 5-HT1B receptor differs depending upon its location. In the frontal cortex, it is believed to act as a terminal receptor inhibiting the release of dopamine. In the basal ganglia and the striatum, evidence suggests 5-HT signaling acts on an autoreceptor, inhibiting the release of serotonin[5] and decreasing glutamatergic transmission by reducing miniature excitatory postsynaptic potential (mEPSP) frequency,[6] respectively. In the hippocampus, a recent study has demonstrated that activation of postsynaptic 5-HT1B heteroreceptors produces a facilitation in excitatory synaptic transmission which is altered in depression.[7] When the expression of 5-HT1B in human cortex was traced throughout life, significant changes during adolescence were observed, in a way that is strongly correlated with the expression of 5-HT1E.[8]

Outside of the CNS, the 5-HT1B receptor is also expressed on the endothelium of blood vessels, particularly in the meninges.[9] Activation of these receptors results in vasoconstriction. The high distribution of vasoconstrictive 5-HT1B and 5-HT1D receptors around the brain makes them a valuable drug target for the treatment of migraines.

Blocking 5-HT1B receptor signalling also increases the number of osteoblasts, bone mass, and the bone formation rate.[10]

Knockout mice lacking the 5-HT1B gene have been reported to have a higher preference for alcohol, although later studies failed to replicate such abnormalities in alcohol consumption.[11] These mice have also been reported to have a lower measure of anxiety (such as on the elevated plus maze test) and a higher measure of aggression.

Under basal conditions, knockout mice present with a "normal" phenotype and exhibit a sucrose preference (lack of sucrose preference is considered a measure of anhedonia). However, after undergoing chronic unpredictable stress treatment to induce a "depression-like" phenotype these animals do not benefit from administration of selective serotonin reuptake inhibitor (SSRIs).

Ligands

Agonists

Partial agonists

Antagonists and inverse agonists

Undetermined Action

Genetics

In humans the protein is coded by the gene HTR1B.

A genetic variant in the promoter region, A-161T, has been examined with respect to personality traits and showed no major effect.[16]

See also

Further reading

External links

Notes and References

  1. Jin H, Oksenberg D, Ashkenazi A, Peroutka SJ, Duncan AM, Rozmahel R, Yang Y, Mengod G, Palacios JM, O'Dowd BF . Characterization of the human 5-hydroxytryptamine1B receptor . The Journal of Biological Chemistry . 267 . 9 . 5735–8 . Mar 1992 . 10.1016/S0021-9258(18)42612-9 . 1348246 . free .
  2. Sanders AR, Cao Q, Taylor J, Levin TE, Badner JA, Cravchik A, Comeron JM, Naruya S, Del Rosario A, Salvi DA, Walczyk KA, Mowry BJ, Levinson DF, Crowe RR, Silverman JM, Gejman PV . Genetic diversity of the human serotonin receptor 1B (HTR1B) gene . Genomics . 72 . 1 . 1–14 . Feb 2001 . 11247661 . 10.1006/geno.2000.6411 .
  3. Web site: Entrez Gene: HTR1B 5-hydroxytryptamine (serotonin) receptor 1B.
  4. Web site: 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled. 23 Feb 2013.
  5. Pytliak M, Vargová V, Mechírová V, Felšöci M . Serotonin receptors - from molecular biology to clinical applications . Physiological Research . 60 . 1 . 15–25 . 2011 . 20945968 . 10.33549/physiolres.931903 . free .
  6. Huang CC, Yeh CM, Wu MY, Hsu KS . A single in vivo cocaine administration impairs 5-HT(1B) receptor-induced long-term depression in the nucleus accumbens . Journal of Neurochemistry . 125 . 6 . 809–21 . Jun 2013 . 23452061 . 10.1111/jnc.12227 . 45859780 . free .
  7. Cai X, Kallarackal AJ, Kvarta MD, Goluskin S, Gaylor K, Bailey AM, Lee HK, Huganir RL, Thompson SM . Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression . Nature Neuroscience . 16 . 4 . 464–72 . Apr 2013 . 23502536 . 10.1038/nn.3355 . 3609911.
  8. Shoval G, Bar-Shira O, Zalsman G, John Mann J, Chechik G . Transitions in the transcriptome of the serotonergic and dopaminergic systems in the human brain during adolescence . European Neuropsychopharmacology . 24 . 7 . 1123–32 . Jul 2014 . 24721318 . 10.1016/j.euroneuro.2014.02.009 . 14534307 .
  9. Tepper SJ, Rapoport AM, Sheftell FD . Mechanisms of action of the 5-HT1B/1D receptor agonists . Archives of Neurology . 59 . 7 . 1084–1088 . July 2002 . 12117355 . 10.1001/archneur.59.7.1084 . free .
  10. Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Schütz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL, Mann JJ, Hen R, Ducy P, Karsenty G . Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum . Cell . 135 . 5 . 825–37 . Nov 2008 . 19041748 . 2614332 . 10.1016/j.cell.2008.09.059.
  11. Hoyer D, Hannon JP, Martin GR . Molecular, pharmacological and functional diversity of 5-HT receptors . Pharmacology Biochemistry and Behavior . 71 . 4 . 533–54 . Apr 2002 . 11888546 . 10.1016/S0091-3057(01)00746-8 . 25543069 .
  12. Hudzik TJ, Yanek M, Porrey T, Evenden J, Paronis C, Mastrangelo M, Ryan C, Ross S, Stenfors C . Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist . The Journal of Pharmacology and Experimental Therapeutics . 304 . 3 . 1072–84 . Mar 2003 . 12604684 . 10.1124/jpet.102.045468 . 20463714 .
  13. Selkirk JV, Scott C, Ho M, Burton MJ, Watson J, Gaster LM, Collin L, Jones BJ, Middlemiss DN, Price GW . SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity . British Journal of Pharmacology . 125 . 1 . 202–8 . Sep 1998 . 9776361 . 1565605 . 10.1038/sj.bjp.0702059 .
  14. Roberts C, Watson J, Price GW, Middlemiss DN . SB-236057-A: a selective 5-HT1B receptor inverse agonist . CNS Drug Reviews . 7 . 4 . 433–44 . 2001 . 11830759 . 10.1111/j.1527-3458.2001.tb00209.x . 6741665 .
  15. Nguyen L, Thomas KL, Lucke-Wold BP, Cavendish JZ, Crowe MS, Matsumoto RR. 2016. Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacol. Ther.. 159. 1–22. 26826604. 10.1016/j.pharmthera.2016.01.016.
  16. Tsai SJ, Wang YC, Chen JY, Hong CJ . Allelic variants of the tryptophan hydroxylase (A218C) and serotonin 1B receptor (A-161T) and personality traits . Neuropsychobiology . 48 . 2 . 68–71 . 2003 . 14504413 . 10.1159/000072879 . 42559772 .